<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="en">
		<id>http://52.89.179.207/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MurrayBrush1</id>
		<title>D&amp;D 5e - User contributions [en]</title>
		<link rel="self" type="application/atom+xml" href="http://52.89.179.207/api.php?action=feedcontributions&amp;feedformat=atom&amp;user=MurrayBrush1"/>
		<link rel="alternate" type="text/html" href="http://52.89.179.207/Special:Contributions/MurrayBrush1"/>
		<updated>2026-08-21T03:01:49Z</updated>
		<subtitle>User contributions</subtitle>
		<generator>MediaWiki 1.29.2</generator>

	<entry>
		<id>http://52.89.179.207/index.php?title=AstraZeneca_Says_Has_Submitted_Full_Data_For_European_Approval_Of...&amp;diff=6128</id>
		<title>AstraZeneca Says Has Submitted Full Data For European Approval Of...</title>
		<link rel="alternate" type="text/html" href="http://52.89.179.207/index.php?title=AstraZeneca_Says_Has_Submitted_Full_Data_For_European_Approval_Of...&amp;diff=6128"/>
				<updated>2021-04-19T15:10:44Z</updated>
		
		<summary type="html">&lt;p&gt;MurrayBrush1: Created page with &amp;quot;&amp;lt;br&amp;gt;LONDON,  [https://www.blog.gatenz-panel.com/ smm panel indonesia] Dec 30 (Reuters) - AstraZeneca has submitted full data to pursue a conditional marketing authorisation ap...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;&amp;lt;br&amp;gt;LONDON,  [https://www.blog.gatenz-panel.com/ smm panel indonesia] Dec 30 (Reuters) - AstraZeneca has submitted full data to pursue a conditional marketing authorisation application from the European Medicines Agency, a spokesman said on Wednesday after an EMA official said more data was needed.&amp;lt;br&amp;gt; &amp;lt;br&amp;gt;&amp;quot;We can confirm that the we have submitted a full data package to support an application for conditional marketing authorisation for the AstraZeneca COVID-19 vaccine to the European Medicines Agency,&amp;quot; the spokesman said.&amp;lt;br&amp;gt; &amp;lt;br&amp;gt;&amp;quot;AstraZeneca has been submitting data on a rolling basis and will continue to work closely with the EMA to support the start of a formal CMA application process.&amp;quot; (Reporting by Alistair Smout; editing by David Evans)&amp;lt;br&amp;gt;&lt;/div&gt;</summary>
		<author><name>MurrayBrush1</name></author>	</entry>

	<entry>
		<id>http://52.89.179.207/index.php?title=User:MurrayBrush1&amp;diff=6127</id>
		<title>User:MurrayBrush1</title>
		<link rel="alternate" type="text/html" href="http://52.89.179.207/index.php?title=User:MurrayBrush1&amp;diff=6127"/>
				<updated>2021-04-19T15:10:42Z</updated>
		
		<summary type="html">&lt;p&gt;MurrayBrush1: Created page with &amp;quot;I'm Murray and I live in a seaside city in northern United States, Charleston. I'm 32 and I'm will soon finish my study at Asian Studies.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Feel free to surf to my web bl...&amp;quot;&lt;/p&gt;
&lt;hr /&gt;
&lt;div&gt;I'm Murray and I live in a seaside city in northern United States, Charleston. I'm 32 and I'm will soon finish my study at Asian Studies.&amp;lt;br&amp;gt;&amp;lt;br&amp;gt;Feel free to surf to my web blog [https://www.blog.gatenz-panel.com/ smm panel indonesia]&lt;/div&gt;</summary>
		<author><name>MurrayBrush1</name></author>	</entry>

	</feed>